Ambulatory Surgery for Urogenital Prolapse : a Pilot Study (PCAP)

Main objective is evaluation of success rate of ambulatory surgery (AS) for pelvic organ prolapse (POP). All surgical approaches (laparoscopic, vaginal) are included in the study. Secondary objectives are AS rate in the overall population and reasons for ineligibility or failure of ambulatory surgery. This pilot study will evaluate the feasibility of AS for POP and identify pitfalls in AS. A randomized control study will follow PCAP study.

The prolapse surgery will be performed in 13% of women. Improved surgical and anesthetic techniques available makes this surgery to ambulatory care, while the latter is only slightly conducted in France. Main objective is evaluation of success rate of ambulatory surgery (AS) for pelvic organ prolapse (POP). All surgical approaches (laparoscopic, vaginal) are included in the study. Secondary objectives are AS rate in the overall population and reasons for ineligibility or failure of ambulatory surgery. This pilot study will evaluate the feasibility of AS for POP and identify pitfalls in AS. A randomized control study will follow PCAP study.

All the patients operated for pelvic organ prolapse during the study time will be recruited. All the patient eligible for an Ambulatory surgery will be discharged earlier.

All patients who accepting participation to the study and operated for prolapse surgery, Patient eligible for Ambulatory surgery and return home on the same day if delivery criteria are satisfied ( Chung criteria+tsuccessful trial of void) Patient not eligible for Ambulatory surgery are included as control group

Success rate = (number of patients with period of hospitalization < 12 hours)/ (number of patients operated for prolapsus)

Inclusion Criteria: Age > 18 years Planned POP surgery Valid social insurance French spoken and written Informed consent signed No exclusion criteria Exclusion Criteria: Refuse participation to study Pregnant or lactating woman Vulnerable people (Article L 1121-6 of the french code of public health) Major subject to legal protection or unable to consent (Article 1121-8 of the french code of public health ) Participation in another protocol for less than 3 months Patient not presenting all the inclusion criteria.